The use of innovative domestic interferon inducer for the prevention and treatment of acute respiratory viral infections in children

Abstract

The article presents data on the place of the modern endogenous interferon inducers in the treatment and prevention of influenza and ARVI in children and the mechanisms of action. The focus is on the domestic antiviral innovation Kagocel which demonstrated high clinical efficacy and safety in a number of multi-center, blind, placebo-controlled studies of the treatment and prevention of ARVI/flu in children over 2 years old.

Keywords

• дети
• профилактика и лечение орви/гриппа
• индукторы интерферона
• кагоцел
• children
• prevention and treatment of arvi/flu
• interferon inducers
• kagocel